Jan Mattsson - Jan 18, 2022 Form 4 Insider Report for ALBIREO PHARMA, INC. (ALBO)

Role
Chief Scientific Officer
Signature
/s/ Jason Duncan, Attorney-in-fact
Stock symbol
ALBO
Transactions as of
Jan 18, 2022
Transactions value $
$0
Form type
4
Date filed
1/20/2022, 03:54 PM
Next filing
Jan 25, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALBO Common Stock Award $0 +21.6K +57.49% $0.00 59.2K Jan 18, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest as to 25% of the shares on January 18, 2023, with the remainder vesting in equal installments every three months thereafter beginning on April 18, 2023 and ending on January 18, 2026.
F2 Represents 32,074 shares of common stock and 27,100 restricted stock units.